GHDX News and Press, Genomic Health Inc. From 10/21/19

Original Post Editor's Note : The summary bullets for this article were chosen by Seeking Read more ...

NEW YORK , Oct. 17, 2019 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City , is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary duties and other violations of law rel...

A handful of genetic testing stocks rolled off all-time highs last month. Shares of NeoGenomics (NASDAQ: NEO) led the peer group by shedding 23.5% in September, according to data from  S&P Global Market Intelligence . That was closely followed by a tumble of 20.6% for shares of Inv...

Exact Sciences (NASDAQ: EXAS) markets a diagnostic test called Cologuard for the detection of colorectal cancer, the second deadliest cancer in America with more than 51,000 deaths annually. Early detection can be life-changing. According to the company, 90% of patients can live for five yea...

Clinical Outcomes in Patients with High Recurrence Score® Results Presented Today in Oral Session at ESMO 2019 Congress With Fourth Peer-Reviewed Publication, TAILORx Continues to Elevate Oncotype DX® Test to a New Global Standard REDWOOD CITY, California , Sept. 30,...

NEW YORK, NY / ACCESSWIRE / September 26, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Avedro, Inc. ( AVDR ) ("Avedro") regard...

NEW YORK, NY / ACCESSWIRE / September 19, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Genomic Health, Inc. (NASDAQ: GHDX ) ("G...

Merger activity increased last week with two new deals announced and two deals closing. Deal Statistics: New Deals: The acquisition of United Community Financial (UCFC) by First Defiance Financial (FDEF) for $473 million in an all-stock deal. Under the terms of the merger agre...

NEW YORK, NY / ACCESSWIRE / September 13, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Genomic Health, Inc. (NASDA...

NEW YORK, NY / ACCESSWIRE / September 10, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Genomic Health, Inc. (NASDAQ: ...